Stockwinners Market Radar for January 13, 2019 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:19 EDT Fly Intel: Top five weekend stock stories - Catch up on the weekend's top five stories with this list compiled by The Fly: 1. PG&E (PCG) is said to be in talks with investment banks about a financing package to help navigate bankruptcy proceedings, a sign that Chapter 11 filing preparations are intensifying in the wake of potentially staggering liabilities from wildfires, according to Reuters, citing sources. 2. As many as 370,000 Volkswagen (VLKAY) diesel cars could be recalled or pulled off the road in Europe if Germany's transport regulator concludes the company cheated when it fixed polluting vehicles, Bloomberg reported, citing Bild am Sonntag newspaper. The regulator accuses the carmaker of manipulating emissions-related software on vehicles with 1.2-liter engines, the newspaper said. 3. With Apple (AAPL) shares down nearly a third in the past three months and the financial guidance bombshell earlier this year, the burning question turns to what the company can do to spark a turnaround, Tae Kim wrote in this week's edition of Barron's. Apple has hinted that it will act boldly to revive its fortunes, and while flashy takeover candidates like Netflix (NFLX) and Tesla (TSLA) often get mentioned, their elevated valuations and cash burn do not match Apple's love for a high profit margins and financial conservatism, the publication noted. The best fit for the iPhone maker may be Nintendo (NTDOY), as both companies have similar attributes like mountains of cash, gushing profits, beloved brands, loyal customers, and sticky ecosystems of software and services, Barron's added. 4. STXfilms' "The Upside" beat AT&T (T) subsidiary Warner Bros' "Aquaman" over the weekend with $19.6M. This was the first time a tittle from STX has opened at number 1, as well as marking the second-biggest debut for STX behind 2016's "Bad Moms" with $23.8M. The film earned an A CinemaScore and sports a 39% Rotten Tomatoes score. 5. Bristol-Myers Squibb (BMY), Estee Lauder (EL), Expeditors International of Washington (EXPD), Nike (NKE), Starbucks (SBUX), Texas Instruments (TXN), Tractor Supply (TSCO), Visa (V), and A.O. Smith (AOS) saw positive mentions in Barron's.

17:41 EDT Aslan announces results from Phase 2 study of Varlitinib in gastric cancer - Aslan Pharmaceuticals announced an update on its global placebo-controlled, double-blind phase 2 clinical study of varlitinib as a first-line therapy in HER1/HER2 co-expressing advanced or metastatic gastric cancer patients, comparing varlitinib plus mFOLFOX6 to placebo plus mFOLFOX6. In the recently completed study, varlitinib did not meet the primary endpoint of significant reductions in tumor size after 12 weeks of treatment. Based on independent central review, patients treated with varlitinib plus mFOLFOX6 had an average tumour shrinkage of 22.0% after 12 weeks compared to 12.5% for patients treated with mFOLFOX6 alone. This difference did not reach statistical significance. Upon review of 17 progression free survival events to date, there was a trend toward an improvement in PFS in patients treated with varlitinib. Overall patient characteristics were well-balanced between the two arms with the exception of baseline ECOG status. The proportion of patients with the best performance status was substantially higher in the control arm than in the varlitinib arm.Varlitinib in combination with mFOLFOX6 was very well-tolerated with 73.1% of patients taking varlitinib experiencing a grade 3 or higher adverse event compared to 88.5% of patients taking mFOLFOX6 alone. Aslan will continue to analyze data from this study, working with study investigators on the future publication of these results, and will focus on development in biliary tract cancer and other indications where varlitinib has shown activity.

12:23 EDT Tanzanian Royalty announces sale of common shares of $885,734 - Tanzanian Royalty's Board of Directors announced the entering into subscription agreements for the sale of 3,924,386 common shares raising $885,734 in the aggregate with two investors. The proceeds from the sale of common shares will be used in furtherance of the company's Three-Phase Drill Program at the Buckreef Project previously announced. The common shares are being offered pursuant to an effective shelf registration statement on Form F-3, that was previously filed with the Securities and Exchange Commission and declared effective on September 5, 2018. The sale of the common shares is expected to close on or before on January 16, 2019, subject to the satisfaction of customary closing conditions, including acceptance of the listing of the common shares by the NYSE American and the Toronto Stock Exchange.

12:19 EDT Stellus Capital declares Q1 regular dividend of 34c per share - Stellus Capital announced that its Board of Directors has declared a regular monthly dividend for each of January, February, and March for an aggregate of 34c per share.